News
-
MIP Diagnostics aims to improve success of rapid COVID-19 tests
A biotech company which produces synthetic antibodies has launched a new product that could improve the success of rapid sensors in detecting Covid-... Read More
-
Microbiotica completes move to new headquarters
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, has finalised its move to purpose-configured facilities at... Read More
-
Battery tech pioneer sets up Boston US operation
Nyobolt, the original founders of ultra-fast charging niobium-based battery technology, has expanded its global footprint with the launch of its... Read More
-
Cambridge scientists unite to discover origin and meaning of life on earth
Cambridge University is driving an historic initiative to learn more about the origins of life on Earth and throughout the Universe in a move that... Read More
-
NATO tasks Marshall with front line CommsTech mission
Front line communications designed to repel physical and cyber attacks and protect NATO allies are to be further enhanced by Cambridge’s Marshall... Read More
-
Law firm expands to US with new Boston base
International law firm Withers, whose life sciences team is based in Cambridge UK, has expanded its technology practice to the US with the hire of a... Read More
-
Bolt from the light blue as HexagonFab strikes it rich in medical sensing
Cambridge-based HexagonFab is targeting global success after raising £1.9 million to accelerate development of novel technology for process... Read More
-
DeepMind ace joins Cambridge Quantum Computing
Cambridge Quantum Computing has secured a major coup by hiring DeepMind’s Professor Stephen Clark as head of Artificial Intelligence. At... Read More
-
Hastings joins Mills & Reeve from Bayer Crop Science
Maggie Hastings has joined Mills & Reeve as a senior legal adviser, bringing a wealth of in-house experience within the life sciences industry... Read More
-
AstraZeneca gets US clearance for $39bn acquisition of Alexion
AstraZeneca's proposed $39 billion acquisition of Alexion Pharmaceuticals, Inc has achieved an important step toward completion, having cleared US... Read More
-
Marshall Motor Holdings mourns death of iconic chairman
Almost 1,000 tributes had been received by Marshall Motor Holdings plc within 72 hours of the death of its cherished chairman Richard Parry-Jones... Read More
-
Porvair share price on the up
Porvair plc, the specialist filtration and environmental technology group based in King’s Lynn saw its share price rise 18p (3.16 per cent) to 587p... Read More
-
Government orders official probe into $40bn NVIDIA bid for Arm
NVIDIA’s proposed $40 billion takeover of Cambridge superchip architect Arm is under official and potentially decisive scrutiny by the UK government... Read More
-
Phico lands up to $18.2m to advance antibacterial therapy
Cambridge biotech business Phico Therapeutics could earn as much as £18.2 million in grant funding and milestone payments from Boston US antibiotics... Read More
-
US investors back $82m Series A for Alchemab
US investment power players have piled into a stunning $82 million Series A round for young biotech business Alchemab Therapeutics whose R & D... Read More
-
£7.4m underpins low carbon hydrogen plant at Cranfield University
A new 1.5 MWth pilot plant is being built at Cranfield University to test an innovative hydrogen production technology that substantially reduces... Read More
-
Thoroughbred Streets shows horse sense with bloodstock expansion
Thoroughbred chartered accountancy firm Streets has formed a dedicated bloodstock business which it hopes will bring in fresh national and global... Read More
-
Quixant back in the black despite Covid backdrop
Quixant, which provides technology products principally for the gaming and broadcast industries from its Cambridge HQ, reports revenue of $63.8... Read More
-
All cheers and no booze as Treatt fortunes rocket
Global demand for healthier living is driving a revenue surge for natural ingredients manufacturer Treatt plc and has sent its UK share price soaring... Read More
-
CyanConnode bridges Gulf with timely Dubai deal
Cambridge technology company CyanConnode saw its UK share price tick up almost 10 per cent to an admittedly modest 9.25p after winning a timely piece... Read More